120 related articles for article (PubMed ID: 17262724)
1. Sentinel lymph node biopsy is feasible even after total mastectomy.
Intra M; Veronesi P; Gentilini OD; Trifirò G; Berrettini A; Cecilio R; Colleoni M; Rietjens M; Luini A; Paganelli G; Veronesi U
J Surg Oncol; 2007 Feb; 95(2):175-9. PubMed ID: 17262724
[TBL] [Abstract][Full Text] [Related]
2. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
[TBL] [Abstract][Full Text] [Related]
3. Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of Oncology.
Intra M; Viale G; Vila J; Grana CM; Toesca A; Gentilini O; Galimberti V; Veronesi P; Luini A; Rotmensz N; Bagnardi V; Mattar D; Colleoni M
Ann Surg Oncol; 2015 Jul; 22(7):2372-7. PubMed ID: 25515197
[TBL] [Abstract][Full Text] [Related]
4. A prospective validation study of sentinel lymph node biopsy in multicentric breast cancer: SMMaC trial.
van la Parra RF; de Roos WK; Contant CM; Bavelaar-Croon CD; Barneveld PC; Bosscha K
Eur J Surg Oncol; 2014 Oct; 40(10):1250-5. PubMed ID: 24685336
[TBL] [Abstract][Full Text] [Related]
5. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence.
Intra M; Trifirò G; Galimberti V; Gentilini O; Rotmensz N; Veronesi P
Br J Surg; 2007 Oct; 94(10):1216-9. PubMed ID: 17583891
[TBL] [Abstract][Full Text] [Related]
6. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
9. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology.
Gentilini O; Trifirò G; Soteldo J; Luini A; Intra M; Galimberti V; Veronesi P; Silva L; Gandini S; Paganelli G; Veronesi U
Eur J Surg Oncol; 2006 Jun; 32(5):507-10. PubMed ID: 16595168
[TBL] [Abstract][Full Text] [Related]
11. [Sentinel node biopsy after multiple breast and axillary surgeries].
Peres A; Delpech Y; Bricou A; Barranger E
Gynecol Obstet Fertil; 2010 Jun; 38(6):415-7. PubMed ID: 20576554
[TBL] [Abstract][Full Text] [Related]
12. Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer.
Sabel MS; Degnim A; Wilkins EG; Diehl KM; Cimmino VM; Chang AE; Newman LA
Am J Surg; 2004 Jun; 187(6):673-8. PubMed ID: 15191855
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
14. Axillary recurrence after sentinel lymph node biopsy.
van der Vegt B; Doting MH; Jager PL; Wesseling J; de Vries J
Eur J Surg Oncol; 2004 Sep; 30(7):715-20. PubMed ID: 15296984
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
16. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
17. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
18. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
19. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
20. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]